ceronapril has been researched along with enalapril in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badia, MC; Cushman, DW; DeForrest, JM; Dejneka, T; Karanewsky, DS; Loots, MJ; Perri, MG; Petrillo, EW; Powell, JR | 1 |
| Katsumura, H; Ogawa, N; Ohara, N; Ono, H; Takizawa, M; Yokota, S | 1 |
| Barnes, NM; Costall, B; Egli, P; Horovitz, ZP; Ironside, JW; Naylor, RJ; Williams, TJ | 1 |
| Hiwada, K; Inoue, Y; Kokubu, T | 1 |
| Cushman, DW; DeForrest, JM; Fung, WC; Grover, GJ; Harvey, CM; Mitch, SL; Scalese, RJ; Wang, FL | 1 |
| Amidon, GL; Friedman, DI | 1 |
| Ikeda, M; Kishi, K | 1 |
| Chong, S; Irwin, WJ; Marino, AM; Moore, VA; Morrison, RA; Timmins, P; Wasserman, MA | 1 |
8 other study(ies) available for ceronapril and enalapril
| Article | Year |
|---|---|
(Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme (ACE). 1. Discovery of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L -proline a novel orally active inhibitor of ACE.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Indicators and Reagents; Lung; Magnetic Resonance Spectroscopy; Male; Optical Rotation; Organophosphorus Compounds; Proline; Rabbits; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1988 |
Hypotensive effect of a phosphorus-containing novel angiotensin converting enzyme inhibitor, (S)-1-[6-amino-2[[hydroxy(4-phenylbutyl)phosphinyl] oxy]-1-oxohexyl]-L-proline (SQ 29,852) in conscious hypertensive dogs.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Dogs; Enalapril; Female; Hypertension; Organophosphorus Compounds; Proline; Renin | 1992 |
Characterisation of [3H]ceranapril recognition sites in rat and human brain tissue.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Animals; Binding Sites; Brain; Captopril; Enalapril; Female; Fosinopril; Humans; Kinetics; Lisinopril; Male; Middle Aged; Organophosphorus Compounds; Proline; Rats; Thiorphan | 1991 |
Effect of SQ29,852, a new angiotensin converting enzyme (ACE) inhibitor with a phosphonic acid group, on the activity of angiotensin converting enzyme from human kidney.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Enalaprilat; Humans; Kidney; Kinetics; Organophosphorus Compounds; Peptidyl-Dipeptidase A; Proline; Protease Inhibitors | 1990 |
Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Bridged Bicyclo Compounds; Captopril; Chemotherapy, Cancer, Regional Perfusion; Dose-Response Relationship, Drug; Enalapril; Fosinopril; Heart; Hypertension; Lisinopril; Male; Organophosphorus Compounds; Proline; Ramipril; Rats; Time Factors; Tissue Distribution | 1989 |
Intestinal absorption mechanism of dipeptide angiotensin converting enzyme inhibitors of the lysyl-proline type: lisinopril and SQ 29,852.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cephradine; Chromatography, High Pressure Liquid; Enalapril; In Vitro Techniques; Intestinal Absorption; Kinetics; Lisinopril; Organophosphorus Compounds; Proline; Rats; Spectrophotometry, Ultraviolet | 1989 |
Chronic effects of SQ29,852, a new angiotensin converting enzyme (ACE) inhibitor with a phosphonic acid group, in experimental hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Enalapril; Hypertension, Renovascular; Male; Organophosphorus Compounds; Proline; Rats; Rats, Inbred SHR | 1993 |
Suitability of enalapril as a probe of the dipeptide transporter system: in vitro and in vivo studies.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biological Transport; Caco-2 Cells; Cefaclor; Dipeptides; Dogs; Dose-Response Relationship, Drug; Enalapril; Humans; In Vitro Techniques; Intestinal Absorption; Jejunum; Male; Models, Biological; Organophosphorus Compounds; Permeability; Proline; Rats | 1996 |